150 related articles for article (PubMed ID: 35953765)
1. Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.
Kumar R; Thakur AK; Banerjee N; Kumar A; Gaurav GK; Arya RK
Drug Deliv Transl Res; 2023 Feb; 13(2):400-418. PubMed ID: 35953765
[TBL] [Abstract][Full Text] [Related]
2. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
3. Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives.
Kumar R; Thakur AK; Kali G; Pitchaiah KC; Arya RK; Kulabhi A
Drug Deliv Transl Res; 2023 Apr; 13(4):946-965. PubMed ID: 36575354
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of apigenin nanoparticles using antisolvent crystallization technology: A comparison of supercritical antisolvent, ultrasonic-assisted liquid antisolvent, and high-pressure homogenization technologies.
Yan T; Wang H; Song X; Yan T; Ding Y; Luo K; Zhen J; He G; Nian L; Wang S; Wang Z
Int J Pharm; 2022 Aug; 624():121981. PubMed ID: 35792228
[TBL] [Abstract][Full Text] [Related]
6. Effect of high pressure homogenization on physicochemical properties of curcumin nanoparticles prepared by antisolvent crystallization using HPMC or PVP.
Homayouni A; Sohrabi M; Amini M; Varshosaz J; Nokhodchi A
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():185-196. PubMed ID: 30813018
[TBL] [Abstract][Full Text] [Related]
7. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
[TBL] [Abstract][Full Text] [Related]
10. Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization.
Homayouni A; Amini M; Sohrabi M; Varshosaz J; Nokhodchi A
Int J Pharm; 2019 May; 562():124-134. PubMed ID: 30898640
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
12. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review.
Padrela L; Rodrigues MA; Duarte A; Dias AMA; Braga MEM; de Sousa HC
Adv Drug Deliv Rev; 2018 Jun; 131():22-78. PubMed ID: 30026127
[TBL] [Abstract][Full Text] [Related]
13. Supercritical CO
Sadeghi F; Kamali H; Kouhestanian S; Hadizadeh F; Nokhodchi A; Afrasiabi Garekani H
Pharm Dev Technol; 2022 Dec; 27(10):999-1008. PubMed ID: 36322612
[TBL] [Abstract][Full Text] [Related]
14. Antisolvent membrane crystallization of pharmaceutical compounds.
Di Profio G; Stabile C; Caridi A; Curcio E; Drioli E
J Pharm Sci; 2009 Dec; 98(12):4902-13. PubMed ID: 19655372
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR.
Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L
J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557
[TBL] [Abstract][Full Text] [Related]
16. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
Murnane D; Marriott C; Martin GP
Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
[TBL] [Abstract][Full Text] [Related]
17. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
[TBL] [Abstract][Full Text] [Related]
18. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
[TBL] [Abstract][Full Text] [Related]
19. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
[TBL] [Abstract][Full Text] [Related]
20. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
Tran P; Park JS
Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
